Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fortress Biotech Inc.

http://www.fortressbiotech.com

Latest From Fortress Biotech Inc.

Zydus Lifesciences MD On Rare Disease Focus, Outcomes-Based Digital Transformation

Zydus Lifesciences is building a rare disease-focused pipeline as a differentiating strategy, managing director Sharvil Patel tells Scrip in an interview. Innovation and patient centricity at heart, digital initiatives are being implemented to transform the company into a ‘future ready’ healthcare organization

Commercial Business Strategies

Big Pharma’s Busiest Deal-Makers In 2021 Were Less Prolific Than In 2020

Totals for aggregate deals and in the M&A, alliance and divestment categories were similar among the 10 busiest deal makers from 2020 to 2021, but COVID-19 may have driven a more hectic deal-making pace overall in 2020.

Growth Business Strategies

Scrip Asks…What Does 2022 Hold For Biopharma? Part 2: Deal Making, M&A And Financial Markets

Following two record-breaking years for biotech fundraising, stock valuations are heading downwards. Biopharma executives and industry experts surveyed by Scrip anticipate big pharma executing more deals and acquisitions in 2022.

Scrip Asks Deals

Keeping Track: Spectrum Submits Poziotinib; US FDA Approves Daré’s Xaciato, Expands Heron Zynrelef Label

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker

US FDA Performance Tracker Drug Review
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Aevitas Therapeutics, Inc.
    • Altamira Bio
    • Avenue Therapeutics, Inc. (ATXI)
    • Baergic Bio, Inc.
    • Caelum Biosciences Inc.
    • Cellvation, Inc.
    • Checkpoint Therapeutics, Inc.
    • Coronado Biosciences, Inc. (CNDO)
    • Cyprium Therapeutics, Inc.
    • DiaVax Biosciences
    • Helocyte, Inc.
    • Journey Medical Corporation (JMC)
    • Mustang Bio, Inc.
    • Mustang Therapeutics, Inc. (MBIO)
    • National Holdings Corporation
    • Oncogenuity, Inc.
    • Tamid Bio, Inc.
UsernamePublicRestriction

Register